American Journal of Kidney Diseases
Volume 51, Issue 2 , Pages 169-172 , February 2008

Multimodality Prevention of Contrast-Induced Acute Kidney Injury

  • Peter A. McCullough, MD, MPH

      Affiliations

    • Corresponding Author InformationAddress correspondence to Peter A. McCullough, MD, MPH, Divisions of Cardiology, Nutrition, and Preventive Medicine, William Beaumont Hospital, 4949 Coolidge Highway, Royal Oak, MI 48073.

References 

  1. McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin. 2005;21:261–280
  2. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol. 2004;183:1673–1689
  3. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930–936
  4. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Critical Care. 2007;11:R31
  5. McCullough PA, Adam A, Becker CR, et al. Risk Prediction of Contrast-Induced Nephropathy. Am J Cardiol. 2006;98:27–36
  6. Briguori C, Airoldi F, D’Andrea D, et al. Renal insufficiency following contrast media administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115:1211–1217
  7. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329–336
  8. Brar S: A randomized controlled trial for the prevention of contrast induced nephropathy with sodium bicarbonate vs. sodium chloride in persons undergoing coronary angiography (the MEENA trial). Abstract 209-9. Presentation at the 56th Annual Scientific Session of the American College of Cardiology, New Orleans, LA, USA, 24-27 March 2007
  9. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004;110:2837–2842
  10. Stacul F, Adam A, Becker CR, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol. 2006;98:59K–77K
  11. Hoffmann U, Fischereder M, Kruger B, et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol. 2004;15:407–410
  12. Marenzi G, Assanelli E, Marana I, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354:2773–2782
  13. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, et al. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol. 2006;26:287–292
  14. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–1238
  15. McCullough PA, Stacul F, Becker CR, et al. Contrast-Induced Nephropathy (CIN) Consensus Working Panel: Executive Summary. Rev Cardiovasc Med. 2006;7:177–197

PII: S0272-6386(07)01606-X

doi: 10.1053/j.ajkd.2007.12.004

American Journal of Kidney Diseases
Volume 51, Issue 2 , Pages 169-172 , February 2008

Article Tools